Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1960 Jan 9;1(5166):121–122. doi: 10.1136/bmj.1.5166.121

Progestogens and Their Clinical Uses: Part II

G I M Swyer
PMCID: PMC1966149  PMID: 13836157

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEVIS D. C. A. Treatment of habitual abortion. Lancet. 1951 Aug 4;2(6675):207–207. doi: 10.1016/s0140-6736(51)91444-4. [DOI] [PubMed] [Google Scholar]
  2. DE VISSER J., OVERBEEK G. A. A new substance with progestational activity. II. Pharmacological properties. Acta Endocrinol (Copenh) 1956 Aug;22(4):318–329. doi: 10.1530/acta.0.0220318. [DOI] [PubMed] [Google Scholar]
  3. GREENE R., DALTON K. The premenstrual syndrome. Br Med J. 1953 May 9;1(4818):1007–1014. doi: 10.1136/bmj.1.4818.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. JAVERT C. T. Repeated abortion; results of treatment in 100 patients. Obstet Gynecol. 1954 Apr;3(4):420–434. [PubMed] [Google Scholar]
  5. JUNKMANN K. Uber protrahiert wirksame Gestagene. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1954;223(3):244–253. [PubMed] [Google Scholar]
  6. PINCUS G., ROCK J., GARCIA C. R., RICEWRAY E., PANIAGUA M., RODRIGUEZ I. Fertility control with oral medication. Am J Obstet Gynecol. 1958 Jun;75(6):1333–1346. doi: 10.1016/0002-9378(58)90722-1. [DOI] [PubMed] [Google Scholar]
  7. POTS P. Testierung der peroralen Gestagenwirkung von Athinyl-nor-testosteronacetat. Klin Wochenschr. 1958 Sep 1;36(17):824–825. doi: 10.1007/BF01481951. [DOI] [PubMed] [Google Scholar]
  8. ROCK J., GARCIA C. R., PINCUS G. Synthetic progestins in the normal human menstrual cycle. Recent Prog Horm Res. 1957;13:323–346. [PubMed] [Google Scholar]
  9. SAUNDERS F. J., COLTON F. B., DRILL V. A. Progesterone-like activity of a series of 19-nortestosterones. Proc Soc Exp Biol Med. 1957 Apr;94(4):717–720. doi: 10.3181/00379727-94-23063. [DOI] [PubMed] [Google Scholar]
  10. SAUNDERS F. J., DRILL V. A. The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds. Endocrinology. 1956 May;58(5):567–572. doi: 10.1210/endo-58-5-567. [DOI] [PubMed] [Google Scholar]
  11. SAVI C., CIGADA G. Die pharmakologische und therapeutische Wirksamkeit eines synthetischen, peroral aktiven Gestagens. Arzneimittelforschung. 1958 Apr;8(4):210–216. [PubMed] [Google Scholar]
  12. WIED G. L., DAVIS M. E. Comparative activity of progestational agents on the human endometrium and vaginal epithelium of surgical castrates. Ann N Y Acad Sci. 1958 Jul 30;71(5):599–616. doi: 10.1111/j.1749-6632.1958.tb46791.x. [DOI] [PubMed] [Google Scholar]
  13. WILKINS L., JONES H. W., Jr, HOLMAN G. H., STEMPFEL R. S., Jr Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J Clin Endocrinol Metab. 1958 Jun;18(6):559–585. doi: 10.1210/jcem-18-6-559. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES